XVIVO Heart Preservation System Gains European Certification

XVIVO Perfusion AB's Heart Assist Transport system, which uses hypothermic oxygenated perfusion, has received CE certificates, allowing its use in European heart transplant centers. A Lancet study showed this technology significantly reduces severe primary graft dysfunction and improves one-year survival compared to traditional ice storage, potentially transforming access to life-saving transplants.